---
figid: PMC11944580__pharmaceutics-17-00391-g001
figtitle: Mevalonate/cholesterol synthesis pathway
organisms:
- NA
organisms_ner:
- NA
pmcid: PMC11944580
filename: pharmaceutics-17-00391-g001.jpg
figlink: /pmc/articles/PMC11944580/figure/F1/
number: F1
caption: Mevalonate/cholesterol synthesis pathway. Statins inhibit HMG-CoA reductase,
  leading to inhibition of cholesterol synthesis and isoprenoid intermediates. The
  inhibition of isoprenoid intermediates disrupts the activation of G proteins, including
  Ras and Rho
papertitle: 'Simvastatin-Loaded Chitosan-Functionalized PLGA Nanoparticles: Characterization
  and Use in Intimal Hyperplasia Therapy'
reftext: Ashley A. Peters, et al. Pharmaceutics. 2025 Mar;17(3).
year: '2025'
doi: 10.3390/pharmaceutics17030391
journal_title: Pharmaceutics
journal_nlm_ta: Pharmaceutics
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: chitosan | poly-lactic-co-glycolic acid | nanoparticles | intimal hyperplasia
  | peripheral arterial disease | statins
automl_pathway: 0.9223889
figid_alias: PMC11944580__F1
figtype: Figure
redirect_from: /figures/PMC11944580__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11944580__pharmaceutics-17-00391-g001.html
  '@type': Dataset
  description: Mevalonate/cholesterol synthesis pathway. Statins inhibit HMG-CoA reductase,
    leading to inhibition of cholesterol synthesis and isoprenoid intermediates. The
    inhibition of isoprenoid intermediates disrupts the activation of G proteins,
    including Ras and Rho
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Acetyl-CoA
  - HMG-CoA
  - STATINS
  - pyrophosphate
  - Farnesyl
  - proteins
---
